Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

35.99
Delayed Data
As of Feb 05
 -1.08 / -2.91%
Today’s Change
32.67
Today|||52-Week Range
58.46
-36.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues0.0019.8M0.000.00
 
 
Depreciation And Amortization224.0K244.0K251.0K244.0K
 
 
 
 
 
 
Operating ExpensesGross Income-224.0K---251.0K-244.0K
 
 
 
 
General Expenses20.2M21.8M25.1M35.6M
 
 
 
 
 
Research And Development15.5M16.6M18.7M24.4M
 
 
 
 
 
Total Operating Expenses20.5M22.1M25.3M35.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.5M-2.3M-25.3M-35.8M
 
 
 
 
 
Other Expenses827.0K1.1M829.0K828.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.4M-1.2M-24.0M-34.4M
 
 
 
 
 
Net Income-19.4M-1.2M-24.0M-34.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS76.1M80.3M85.5M85.9M
 
 
 
 
 
Shares To Calculate EPS Diluted76.1M80.3M85.5M85.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.01-$0.28-$0.40
 
 
 
 
 
EPS Diluted-$0.26-$0.01-$0.28-$0.40